EC
MRK icon

Elequin Capital’s Merck MRK Stock Holding History

Elequin Capital’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-27
Closed -$3.25K – 838
2026
Q1 		$3.25K Sell
27
-15
-36% -$1.73K ﹤0.01% 436
2025
Q4 		$4.42K Buy
+42
New +$3.94K ﹤0.01% 313
2025
Q2 		– Sell
-44
Closed -$3.95K – 477
2025
Q1 		$3.95K Sell
44
-41
-48% -$3.83K ﹤0.01% 304
2024
Q4 		$8.46K Buy
+85
New +$8.76K ﹤0.01% 365
2023
Q4 		– Sell
-2,200
Closed -$226K – 446
2023
Q3 		$226K Buy
2,200
+2,064
+1,518% +$222K 0.04% 101
2023
Q2 		$15.7K Buy
+136
New +$15.4K 0.01% 254
2022
Q4 		– Sell
-77
Closed -$7K – 682
2022
Q3 		$7K Sell
77
-255
-77% -$22.8K ﹤0.01% 297
2022
Q2 		$30K Buy
+332
New +$29.4K 0.01% 170

Other funds holding MRK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Elequin Capital's MRK Position: Q2 2026 in Review

Elequin Capital sold out of Merck (MRK) in Q2 2026, closing a stake of 27 shares — an estimated $3.25K sold.

Elequin Capital first reported a position in MRK in Q2 2022 and held it in 8 quarters. The position peaked at $226K in Q3 2023. 3,852 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Elequin Capital reported no remaining Merck position as of Q2 2026 after selling out during the quarter.
  • Elequin Capital sold 27 Merck shares in Q2 2026, an estimated $3.25K.
  • Elequin Capital first reported a position in Merck in Q2 2022 and held it in 8 quarters.
  • Elequin Capital's Merck position peaked at $226K in Q3 2023.
  • 3,852 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Elequin Capital's 13F filing for Q2 2026, filed 13 Aug 2026.